Injectable leachable-free hydrogel foams for cell delivery
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Tipo de documento: | Dissertação |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10773/30102 |
Resumo: | Microporosity is often associated with pre-formed scaffolds with pre-defined shapes that are unable to be injected and to withstand cell encapsulation during its manufacturing process. Injectable hydrogels are widely applied in regenerative medicine, since they are capable of withstanding cell encapsulation and to undergo in situ physical or chemical crosslinking. However, the diffusion of nutrients is often limited to 100 – 200 μm within bulk hydrogels with clinically relevant dimensions, leading to the appearance of necrotic cores, or uneven cell response. In addition, the migration of cells is also impaired due to hydrogels’ nanometric pore sizes. Therefore, the combination of injectable hydrogels with microporous structures is desired; however, the techniques currently used to achieve this feature often rely on the use of solid or liquid leaching agents, which may be toxic or locally modulate the host implantation site in unexpected manners. Therefore, the main goal of this project is the development of a cellladen injectable gelatin methacryloyl (GelMA) hydrogel foam, that do not require the use of leaching agents and that is able to be injected and undergo in situ photocrosslinking. GelMA hydrogel foams were prepared by a newly developed syringe foaming technique using a single polymer formulation. When exposed to UV irradiation, the structure of the foam was successfully maintained due to photocrosslinking. Three different conditions were studied: (1) GelMA hydrogels without the introduction of air bubbles (H7s); (2) GelMA foams (F7s) and (3) pre-crosslinked foams in which cells were added after a pre-crosslinking step (F5s2s), aiming at the development of a milder process. Water uptake studies demonstrated that both foam formulations have a high capacity of water uptake and water retention compared to H7s. Moreover, molecule release studies indicated that foams have a lower value of FITCdextran release, serving as potential long-term reservoirs of medium-sized molecules. Cell viability assays showed that H7s samples present a highly proliferative area at its surface after 7 days of cell culture, and liquified core at the center of the biomaterial. In both foam formulations, cell viability was demonstrated throughout the whole structures at all studied time points. Moreover, cell metabolic activity after 7 days of cell culture was higher in F5s2s foams, compared to H7s and F7s conditions. The technique reported here allowed a leachable-free fabrication of injectable fitto-shape GelMA foams combined living cells using a single material formulation. In addition, this strategy allows the in situ crosslinking of the GelMA foam structures in tissue defects. |
id |
RCAP_155d171ff57e0852d95e09fd89a3d2d3 |
---|---|
oai_identifier_str |
oai:ria.ua.pt:10773/30102 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Injectable leachable-free hydrogel foams for cell deliveryTissue engineeringMicroporosityHydrogelsFoamsMicroporosity is often associated with pre-formed scaffolds with pre-defined shapes that are unable to be injected and to withstand cell encapsulation during its manufacturing process. Injectable hydrogels are widely applied in regenerative medicine, since they are capable of withstanding cell encapsulation and to undergo in situ physical or chemical crosslinking. However, the diffusion of nutrients is often limited to 100 – 200 μm within bulk hydrogels with clinically relevant dimensions, leading to the appearance of necrotic cores, or uneven cell response. In addition, the migration of cells is also impaired due to hydrogels’ nanometric pore sizes. Therefore, the combination of injectable hydrogels with microporous structures is desired; however, the techniques currently used to achieve this feature often rely on the use of solid or liquid leaching agents, which may be toxic or locally modulate the host implantation site in unexpected manners. Therefore, the main goal of this project is the development of a cellladen injectable gelatin methacryloyl (GelMA) hydrogel foam, that do not require the use of leaching agents and that is able to be injected and undergo in situ photocrosslinking. GelMA hydrogel foams were prepared by a newly developed syringe foaming technique using a single polymer formulation. When exposed to UV irradiation, the structure of the foam was successfully maintained due to photocrosslinking. Three different conditions were studied: (1) GelMA hydrogels without the introduction of air bubbles (H7s); (2) GelMA foams (F7s) and (3) pre-crosslinked foams in which cells were added after a pre-crosslinking step (F5s2s), aiming at the development of a milder process. Water uptake studies demonstrated that both foam formulations have a high capacity of water uptake and water retention compared to H7s. Moreover, molecule release studies indicated that foams have a lower value of FITCdextran release, serving as potential long-term reservoirs of medium-sized molecules. Cell viability assays showed that H7s samples present a highly proliferative area at its surface after 7 days of cell culture, and liquified core at the center of the biomaterial. In both foam formulations, cell viability was demonstrated throughout the whole structures at all studied time points. Moreover, cell metabolic activity after 7 days of cell culture was higher in F5s2s foams, compared to H7s and F7s conditions. The technique reported here allowed a leachable-free fabrication of injectable fitto-shape GelMA foams combined living cells using a single material formulation. In addition, this strategy allows the in situ crosslinking of the GelMA foam structures in tissue defects.A microporosidade é comummente associada à produção de estruturas de biomateriais pré-fabricadas e com formas pré-definidas, não injetáveis e incapazes de suportar o encapsulamento celular durante o seu processo de produção. Os hidrogéis injetáveis são amplamente utilizados na medicina regenerativa, visto que suportam o encapsulamento celular e podem ser reticulados química ou físicamente in situ. No entanto, a difusão de nutrientes é limitada a cerca 100 – 200 μm de distância dentro de hidrogéis com dimensões clinicamente relevantes, originando centros necróticos ou respostas celulares espacialmente heterogéneas. Adicionalmente, o tamanho nanométrico dos poros presentes nos hidrogéis afeta a migração celular. Logo, a combinação de hidrogéis injetáveis com estruturas microporosas é uma estratégia apelativa. No entanto, as técnicas que se usam atualmente para atingir este objetivo usam agentes lixiviáveis sólidos ou líquidos, que podem ser tóxicos ou modular o local de implantação de formas inesperadas. Desta forma, este projeto tem como objetivo principal o desenvolvimento de espumas de hidrogel injetáveis constituídas por gelatina metacrilada (GelMA), que não requerem o uso de agentes lixiviáveis e que sejam capazes de ser injetadas e de sofrer reticulação in situ. As espumas de GelMA foram produzidas por um novo método recorrendo a uma seringa, usando um único tipo de polímero. Após a exposição a radiação UV, a estrutura das espumas foi mantida com sucesso devido à reticulação. Foram estudadas três condições diferentes: (1) hidrogéis de GelMA sem a introdução de bolhas de ar (H7s); (2) espumas de GelMA (F7s) e (3) espumas de GelMA em que a adição de células se fez após um passo de pré-reticulação (F5s2s), esperando desenvolver um processo mais inofensivo. Os estudos de absorção de água indicam que os dois tipos de espumas têm uma grande capacidade de absorção e retenção de água, comparado com os hidrogéis. Além disso, os estudos sobre a libertação de moléculas indicaram que as espumas têm menor libertação de dextrano-FITC, servindo como potenciais reservatórios de moléculas com tamanhos médios. Ensaios de viabilidade celular indicam que as amostras H7s possuem uma área de proliferação celular bastante acentuada à sua superfície e um núcleo liquefeito no centro, após 7 dias em cultura. Nos dois tipos de espumas, as células permaneceram viáveis em toda a sua extensão. Além disso, a atividade metabólica para as espumas F5s2s é superior às amostras F7s e H7s, após 7 dias em cultura. A técnica reportada neste trabalho permitiu o desenvolvimento de espumas de hidrogel injetáveis, combinadas com células e usando um único tipo de polímero. Estas espumas são livres de lixiviáveis e capazes de se ajustar à forma de um defeito devido à possibilidade de fixação da forma in situ.2019-122019-12-01T00:00:00Z2021-12-10T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10773/30102engSalvador, Tânia Raquel Ferreirainfo:eu-repo/semantics/embargoedAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-02-22T11:58:13Zoai:ria.ua.pt:10773/30102Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:02:17.894191Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Injectable leachable-free hydrogel foams for cell delivery |
title |
Injectable leachable-free hydrogel foams for cell delivery |
spellingShingle |
Injectable leachable-free hydrogel foams for cell delivery Salvador, Tânia Raquel Ferreira Tissue engineering Microporosity Hydrogels Foams |
title_short |
Injectable leachable-free hydrogel foams for cell delivery |
title_full |
Injectable leachable-free hydrogel foams for cell delivery |
title_fullStr |
Injectable leachable-free hydrogel foams for cell delivery |
title_full_unstemmed |
Injectable leachable-free hydrogel foams for cell delivery |
title_sort |
Injectable leachable-free hydrogel foams for cell delivery |
author |
Salvador, Tânia Raquel Ferreira |
author_facet |
Salvador, Tânia Raquel Ferreira |
author_role |
author |
dc.contributor.author.fl_str_mv |
Salvador, Tânia Raquel Ferreira |
dc.subject.por.fl_str_mv |
Tissue engineering Microporosity Hydrogels Foams |
topic |
Tissue engineering Microporosity Hydrogels Foams |
description |
Microporosity is often associated with pre-formed scaffolds with pre-defined shapes that are unable to be injected and to withstand cell encapsulation during its manufacturing process. Injectable hydrogels are widely applied in regenerative medicine, since they are capable of withstanding cell encapsulation and to undergo in situ physical or chemical crosslinking. However, the diffusion of nutrients is often limited to 100 – 200 μm within bulk hydrogels with clinically relevant dimensions, leading to the appearance of necrotic cores, or uneven cell response. In addition, the migration of cells is also impaired due to hydrogels’ nanometric pore sizes. Therefore, the combination of injectable hydrogels with microporous structures is desired; however, the techniques currently used to achieve this feature often rely on the use of solid or liquid leaching agents, which may be toxic or locally modulate the host implantation site in unexpected manners. Therefore, the main goal of this project is the development of a cellladen injectable gelatin methacryloyl (GelMA) hydrogel foam, that do not require the use of leaching agents and that is able to be injected and undergo in situ photocrosslinking. GelMA hydrogel foams were prepared by a newly developed syringe foaming technique using a single polymer formulation. When exposed to UV irradiation, the structure of the foam was successfully maintained due to photocrosslinking. Three different conditions were studied: (1) GelMA hydrogels without the introduction of air bubbles (H7s); (2) GelMA foams (F7s) and (3) pre-crosslinked foams in which cells were added after a pre-crosslinking step (F5s2s), aiming at the development of a milder process. Water uptake studies demonstrated that both foam formulations have a high capacity of water uptake and water retention compared to H7s. Moreover, molecule release studies indicated that foams have a lower value of FITCdextran release, serving as potential long-term reservoirs of medium-sized molecules. Cell viability assays showed that H7s samples present a highly proliferative area at its surface after 7 days of cell culture, and liquified core at the center of the biomaterial. In both foam formulations, cell viability was demonstrated throughout the whole structures at all studied time points. Moreover, cell metabolic activity after 7 days of cell culture was higher in F5s2s foams, compared to H7s and F7s conditions. The technique reported here allowed a leachable-free fabrication of injectable fitto-shape GelMA foams combined living cells using a single material formulation. In addition, this strategy allows the in situ crosslinking of the GelMA foam structures in tissue defects. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-12 2019-12-01T00:00:00Z 2021-12-10T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10773/30102 |
url |
http://hdl.handle.net/10773/30102 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/embargoedAccess |
eu_rights_str_mv |
embargoedAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799137678421131264 |